This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Medshine Discovery Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Zhaoying Xu - Innovator in CXCR2 Antagonist Development
Introduction
Zhaoying Xu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that act as CXCR2 antagonists. His work is crucial for advancing therapeutic options in various medical conditions.
Latest Patents
Zhaoying Xu holds a patent for a CXCR2 antagonist, which is a compound designed to inhibit the CXCR2 receptor. This invention is particularly relevant for preparing drugs that target this receptor. The patent specifically relates to a compound represented by formula (II) or its isomers or pharmaceutically acceptable salts.
Career Highlights
Throughout his career, Zhaoying Xu has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Medshine Discovery Inc. and Shenzhen Optimum Biological Technology Co., Ltd. His experience in these organizations has allowed him to contribute to innovative research and development projects.
Collaborations
Zhaoying Xu has collaborated with several professionals in his field, including Bin Chen and Xiawei Wei. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
Zhaoying Xu is a distinguished inventor whose work on CXCR2 antagonists has the potential to influence drug development significantly. His contributions to the pharmaceutical industry are noteworthy and reflect his commitment to innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile